CDKN2A, but not TP53 and CDKN1A mRNA levels increased between P1 and P4; however, no significant differences were observed in these senescence-associated mRNA levels in OM compared to cells cultured in NM (Figure 3). This evidence concerns the gene TP53 and ocular melanoma.